{"public_id":"cl_2b6fe9b34865d53062b537dc78c07c2e","status":"active","superseded_by_public_id":null,"corpus_id":3692938,"text":"A 4-fold difference in use of antineoplastic drugs and a 49-fold difference in use of targeted therapies were found between regions when the outer islands were included.","confidence":0.95,"paper":{"corpus_id":3692938,"title":"Geographic Variations and Time Trends in Cancer Treatments in Taiwan","url":"https://sah.borca.ai/papers/3692938"},"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_41405c2475ca14077e11256c186a13b8","name":"outer islands","description":"The outer islands of Taiwan, where population-adjusted use and costs of antineoplastic drugs were lowest and where large differences in use were observed.","types":["geographic region"],"url":"https://sah.borca.ai/concepts/co_41405c2475ca14077e11256c186a13b8"},{"public_id":"co_8ffe8ba2318499e14444eeba01f24b13","name":"use of targeted therapies","description":"Utilization of targeted therapies for cancer treatment measured by prescription volume across regions.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_8ffe8ba2318499e14444eeba01f24b13"},{"public_id":"co_c3cbb5b2a268e0b701c66e53ae385dda","name":"use of antineoplastic drugs","description":"Utilization of antineoplastic drugs measured by prescription volume across regions.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_c3cbb5b2a268e0b701c66e53ae385dda"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_2b6fe9b34865d53062b537dc78c07c2e"}